George Anastassov
Directeur/Membre du Conseil chez INCANNEX HEALTHCARE INC.
Fortune : 2 M $ au 30/04/2024
Postes actifs de George Anastassov
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INCANNEX HEALTHCARE INC. | Directeur/Membre du Conseil | 28/06/2022 | - |
| Stichting Sanammad | Directeur/Membre du Conseil | 01/01/2009 | - |
| Fondateur | 01/01/2009 | - | |
| Corporate Officer/Principal | 01/01/2009 | - | |
| Sanammad Pharmaceuticals BV | Directeur/Membre du Conseil | 01/01/2014 | - |
| Fondateur | 01/01/2014 | - | |
| Corporate Officer/Principal | 01/01/2014 | - | |
CanChew License Co.
 CanChew License Co. Miscellaneous Commercial ServicesCommercial Services CanChew License Co. provides licensing services. The company is headquartered in Reno, NV. | Directeur/Membre du Conseil | - | - |
| President | - | - | |
| Secrétaire Général | - | - | |
| Treasurer | - | - |
Historique de carrière de George Anastassov
Anciens postes connus de George Anastassov
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| RYAH GROUP, INC. | Directeur/Membre du Conseil | 21/04/2021 | 06/12/2022 |
APIRX Pharmaceuticals USA LLC
 APIRX Pharmaceuticals USA LLC Pharmaceuticals: OtherHealth Technology APIRX Pharmaceuticals USA LLC is located in the US. Part of Incannex Healthcare, Inc., APIRX Pharmaceuticals USA LLC is an American company that provides research, development, and production of prescription pharmaceutical cannabinoid medicines. The company was founded by George E. Anastassov, Lekhram Changoer. APIRX Pharmaceuticals USA was acquired by Incannex Healthcare, Inc. on August 04, 2022 for $30.91 million. | Fondateur | 01/01/2017 | 01/01/2022 |
| Corporate Officer/Principal | 01/01/2017 | 01/01/2022 | |
| AXIM BIOTECHNOLOGIES, INC. | Directeur Général | 01/05/2014 | 02/01/2019 |
| Président | 01/05/2014 | 06/05/2020 | |
| Directeur Financier/CFO | 01/05/2014 | - | |
| Fondateur | 01/05/2014 | 06/05/2020 | |
| President | 01/05/2014 | 02/01/2019 | |
| Secrétaire Général | 01/05/2014 | - | |
CanChew Biotechnologies LLC
 CanChew Biotechnologies LLC Pharmaceuticals: OtherHealth Technology CanChew Biotech focuses on the treatment of pain and other medical disorders with the application of chewing gum based cannabis/cannabinoids medical products. The company targets on the R&D and execution of their clinical development plan and subsequently out licensing of their technology. The development focuses on the R&D of the formulation, production and the development of chewing gum based products in their respective fields e.g.: for the treatment of numerous diseases like pain, nausea and vomiting, anorexia, spasticity and various other symptoms. | Directeur/Membre du Conseil | 01/01/2012 | - |
| Directeur Général | 30/07/2013 | - | |
| Fondateur | 01/01/2012 | - |
Formation de George Anastassov
| NYU College of Dentistry | Doctorate Degree |
| University of Tennessee | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 8 |
| Pays-Bas | 4 |
Opérationnelle
| Director/Board Member | 6 |
| Founder | 5 |
| Corporate Officer/Principal | 3 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
| Miscellaneous | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| AXIM BIOTECHNOLOGIES, INC. | Health Technology |
| RYAH GROUP, INC. | Technology Services |
| INCANNEX HEALTHCARE INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
CanChew Biotechnologies LLC
CanChew Biotechnologies LLC Pharmaceuticals: OtherHealth Technology CanChew Biotech focuses on the treatment of pain and other medical disorders with the application of chewing gum based cannabis/cannabinoids medical products. The company targets on the R&D and execution of their clinical development plan and subsequently out licensing of their technology. The development focuses on the R&D of the formulation, production and the development of chewing gum based products in their respective fields e.g.: for the treatment of numerous diseases like pain, nausea and vomiting, anorexia, spasticity and various other symptoms. | Health Technology |
| Stichting Sanammad | Miscellaneous |
| Sanammad Pharmaceuticals BV | |
CanChew License Co.
CanChew License Co. Miscellaneous Commercial ServicesCommercial Services CanChew License Co. provides licensing services. The company is headquartered in Reno, NV. | Commercial Services |
APIRX Pharmaceuticals USA LLC
APIRX Pharmaceuticals USA LLC Pharmaceuticals: OtherHealth Technology APIRX Pharmaceuticals USA LLC is located in the US. Part of Incannex Healthcare, Inc., APIRX Pharmaceuticals USA LLC is an American company that provides research, development, and production of prescription pharmaceutical cannabinoid medicines. The company was founded by George E. Anastassov, Lekhram Changoer. APIRX Pharmaceuticals USA was acquired by Incannex Healthcare, Inc. on August 04, 2022 for $30.91 million. | Health Technology |
- Bourse
- Insiders
- George Anastassov
- Expérience
